65. 原発性免疫不全症候群 Primary immunodeficiency Clinical trials / Disease details

臨床試験数 : 482 / 薬物数 : 653 - (DrugBank : 119) / 標的遺伝子数 : 92 - 標的パスウェイ数 : 212

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05256017 (ClinicalTrials.gov)	December 30, 2021	17/1/2022	Safety and Tolerability Study of Acoziborole in g-HAT Seropositive Subjects	Safety and Tolerability Study of Acoziborolein g-HAT Seropositive Non-parasitologically Confirmed Su ...	Trypanosomiasis, African;Trypanosoma Brucei Gambiense; Infection;Sleeping Sickness	Drug: Acoziborole;Drug: Placebo	Drugs for Neglected Diseases	NULL	Recruiting	15 Years	N/A	All	1200	Phase 2/Phase 3	Congo, The Democratic Republic of the;Guinea
2	NCT03087955 (ClinicalTrials.gov)	October 11, 2016	7/3/2017	Prospective Study on Efficacy and Safety of Acoziborole(SCYX-7158) in Patients Infected by Human Afr ...	Efficacy and Safety Study of Acoziborole(SCYX-7158) in Patients With Human African Trypanosomiasis ( ...	Trypanosomiasis, African;Gambiense Trypanosomiasis;Sleeping Sickness	Drug: Acoziborole (SCYX-7158)	Drugs for Neglected Diseases	NULL	Completed	15 Years	N/A	All	260	Phase 2/Phase 3	Congo, The Democratic Republic of the;Guinea

First Previous1Next Last